In October 2022, the Company group's research and development (R&D) organization transitioned to the Deep Human Biology Learning (DHBL) drug discovery and development. Under the DHBL drug discovery ...
(Note) As the Merger falls under a simplified absorption-type merger as prescribed in the Article 796, Paragraph 2 of the Companies Act in Japan for IIJ and a short-form merger as prescribed in the ...
TipRanks on MSN
BIPROGY Inc. announces absorption merger with subsidiary for operational streamlining
An announcement from BIPROGY Inc. ( ($JP:8056) ) is now available. BIPROGY Inc. has announced the absorption-type merger of its wholly owned ...
The merger aims to consolidate and integrate operations, improve efficiency, optimise the use of assets and cash, simplify ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Internet Initiative Japan NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback